Qualified participants will receive study-related care and study medication at no charge as well as receive reimbursement for time and participation.
A high percentage of gastroparesis patients have difficulty with a variety of symptoms from abdominal pain to nausea and vomiting.
The study duration is approximately 4 months with a screening phase of approximately one month prior to randomization to drug or placebo.
Researchers in the United States are looking for up to 400 adults diagnosed with gastroparesis who: